![Mark Iwicki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/07/2026
El Sr. Mark T. Iwicki es presidente de Q32 Bio, Inc., presidente de Akero Therapeutics, Inc., director independiente de Pulmatrix, Inc., director independiente no ejecutivo de Merus NV, presidente y director ejecutivo de Kala Pharmaceuticals, Inc. y director independiente de Aimmune Therapeutics, Inc. Es miembro del Consejo de Administración de Pulmatrix, Inc., Merus NV, Nimbus Therapeutics LLC, Aimmune Therapeutics, Inc., Nimbus Apollo, Inc., Oxeia Biopharmaceuticals, Inc. y Pulmatrix Operating Co. El Sr. Iwicki trabajó anteriormente como Presidente, Director General y Director de Civitas Therapeutics, Inc., Presidente, Director General y Director de Blend Therapeutics, Inc., Presidente y Director General de Sepracor Pharmaceuticals Inc., Vicepresidente de Novartis Pharmaceuticals Corp, Vicepresidente y Jefe de la Unidad de Negocio Cardiovascular de Novartis Pharmaceuticals UK Ltd., Director de Astra Merck, Inc., Director de Merck & Co., Inc. y Presidente y Director General de Sumitomo Dainippon Pharma Co. También formó parte del consejo de administración de TARIS BioMedical LLC y de la Wellesley Youth Hockey Association. Se licenció en la Ball State University (Indiana) y obtuvo un MBA en la Loyola University Maryland, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KALA BIO, INC. -.--% | 29/12/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| 15/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
-.--% | 12/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Presidente | 01/05/2020 |
| INHIBIKASE THERAPEUTICS, INC. | Director Ejecutivo | 14/02/2025 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultor / Asesor | - |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Presidente | 22/12/2020 |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Director/Miembro de la Junta | - |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| KALA BIO, INC. | Director Ejecutivo | 11/02/2025 |
| MERUS N.V. | Presidente | 01/07/2018 |
| AKERO THERAPEUTICS, INC. | Presidente | 09/12/2025 |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 26 |
|---|---|
Sumitomo Pharma Co., Ltd.
 Sumitomo Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and other chemical products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biotechnology company which develops therapeutics for mild traumatic brain injuries and neuro-metabolic dysfunctions | Health Technology |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
Ball State University (Indiana)
 Ball State University (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University Maryland, Inc.
 Loyola University Maryland, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Health Technology |
Wellesley Youth Hockey Association
 Wellesley Youth Hockey Association Movies/EntertainmentConsumer Services Operates as an association for the improvement of hockey | Consumer Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
